Delayed
Australian S.E.
09:09:56 13/05/2024 am IST
|
5-day change
|
1st Jan Change
|
0.076
AUD
|
-2.56%
|
|
-11.63%
|
-6.17%
|
Fiscal Period: June |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
87.75
|
47.35
|
37.2
|
15.03
|
Enterprise Value (EV)
1 |
61.45
|
14.63
|
7.862
|
-7.439
|
P/E ratio
|
-21.7
x
|
-20.7
x
|
-9.41
x
|
-1.94
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
204
x
|
32.7
x
|
EV / Revenue
|
-
|
-
|
43.1
x
|
-16.2
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
EV / FCF
|
51,03,78,25,581
x
|
-65,75,540
x
|
-40,37,550
x
|
16,60,230
x
|
FCF Yield
|
0%
|
-0%
|
-0%
|
0%
|
Price to Book
|
3.6
x
|
1.48
x
|
1.31
x
|
0.71
x
|
Nbr of stocks (in thousands)
|
67,500
|
75,154
|
75,154
|
75,154
|
Reference price
2 |
1.300
|
0.6300
|
0.4950
|
0.2000
|
Announcement Date
|
27/08/20
|
26/08/21
|
18/08/22
|
17/08/23
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
0.000396
|
-
|
-
|
0.1823
|
0.4591
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-0.3811
|
-3.249
|
-2.443
|
-4.033
|
-8.547
|
Operating Margin
|
-96,227.27%
|
-
|
-
|
-2,212.89%
|
-1,861.73%
|
Earnings before Tax (EBT)
1 |
-0.6964
|
-3.36
|
-2.284
|
-3.953
|
-7.75
|
Net income
1 |
-0.6964
|
-3.36
|
-2.284
|
-3.953
|
-7.75
|
Net margin
|
-1,75,850%
|
-
|
-
|
-2,169.06%
|
-1,688.11%
|
EPS
2 |
-0.0295
|
-0.0598
|
-0.0304
|
-0.0526
|
-0.1031
|
Free Cash Flow
|
-
|
0.001204
|
-2.225
|
-1.947
|
-4.481
|
FCF margin
|
-
|
-
|
-
|
-1,068.4%
|
-976.07%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
27/08/19
|
27/08/20
|
26/08/21
|
18/08/22
|
17/08/23
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
12.2
|
26.3
|
32.7
|
29.3
|
22.5
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
0
|
-2.23
|
-1.95
|
-4.48
|
ROE (net income / shareholders' equity)
|
-
|
-18.8%
|
-8.09%
|
-13.1%
|
-31.2%
|
ROA (Net income/ Total Assets)
|
-
|
-10.5%
|
-5.16%
|
-8.1%
|
-20.4%
|
Assets
1 |
-
|
32.09
|
44.25
|
48.79
|
37.93
|
Book Value Per Share
2 |
0.4800
|
0.3600
|
0.4300
|
0.3800
|
0.2800
|
Cash Flow per Share
2 |
0.5200
|
0.3900
|
0.4400
|
0.3900
|
0.3000
|
Capex
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
27/08/19
|
27/08/20
|
26/08/21
|
18/08/22
|
17/08/23
|
|
1st Jan change
|
Capi.
|
---|
| -6.17% | 3.87M | | +17.96% | 44.96B | | +1.17% | 42.65B | | +48.77% | 41.85B | | -4.27% | 29.04B | | +11.42% | 26.08B | | -21.39% | 19.03B | | +4.86% | 12.75B | | +27.29% | 12.06B | | -3.50% | 11.75B |
Other Biotechnology & Medical Research
|